{"id":530303,"date":"2021-08-23T07:03:34","date_gmt":"2021-08-23T11:03:34","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/net-health-partners-with-organogenesis-for-more-efficient-insurance-benefits-verification\/"},"modified":"2021-08-23T07:03:34","modified_gmt":"2021-08-23T11:03:34","slug":"net-health-partners-with-organogenesis-for-more-efficient-insurance-benefits-verification","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/net-health-partners-with-organogenesis-for-more-efficient-insurance-benefits-verification\/","title":{"rendered":"Net Health Partners with Organogenesis for More Efficient Insurance Benefits Verification"},"content":{"rendered":"
\n

Agreement streamlines insurance verification process<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n PITTSBURGH<\/span>, Aug. 23, 2021<\/span> \/PRNewswire\/ — Net Health<\/a>, a leading provider of cloud-based software for specialty medical providers, announced today that Organogenesis Holdings Inc.<\/a>\u00a0(Nasdaq: ORGO), has become the first company to utilize Net Health\u00ae<\/span> Wound Care’s latest CTP Connections Module to electronically submit insurance benefits verification forms. Through this partnership, hospital and outpatient wound care providers can quickly and efficiently verify benefits for Organogenesis’s portfolio of cell and tissue-based products.<\/p>\n

\n

\n
\n \"(PRNewsfoto\/Net
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n Net Health Wound Care<\/a>, formerly WoundExpert\u00ae<\/span>, is the company’s proprietary web-based electronic health record (EHR) platform for wound care management. It is the most widely deployed wound care EHR in the country, used by more than 20,000 clinicians at hospitals and outpatient wound clinics. <\/p>\n

Organogenesis is a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets. Organogenesis Advanced Wound Care (AWC) products are covered by the Medicare Administrative Contractors (MACs) and some have local coverage determinations (LCDs). Additionally, more than 1,500 commercial health insurance plans cover Apligraf\u00ae<\/span> and Dermagraft\u00ae<\/span>, and the rest of Organogenesis’s portfolio of products. <\/p>\n

For reimbursement purposes, most providers verify patient benefits before applying wound care products. The new partnership allows Net Health Wound Care users to securely submit patient information in electronic form, which minimizes the potential for costly administrative errors and produces faster responses from payors.\u00a0<\/p>\n

“Providing timely and effective benefits verification for our products is an important Organogenesis priority,” said Antonio S. Montecalvo<\/span>, Vice President of Health Policy & Contracting of Organogenesis.\u00a0“We are very pleased to partner with Net Health to streamline this process for providers and ensure our patients access to our life-changing and life-saving products.” <\/p>\n

\n Connections Platform<\/b>\n <\/p>\n

The ability to secure insurance verifications for Organogenesis products is included, at no additional cost, to Net Health Wound Care customers. The in-chart ordering functionality, called the Connection Module, benefits clinicians as well as their patients. In addition to the new insurance verification feature, it:\u00a0<\/p>\n